The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Willkie Farr & Gallagher advises PAI Partners on Zydus Lifesciences’ €256.8 million acquisition of Amplitude Surgical’s ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

Zydus Lifesciences rose 1.67% to Rs 897.25 after the firm said that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

Inspection occurred from March 10, 2025 to March 14, 2025 and ended with no observations with full compliance.

Sun Pharmaceutical Industries, Inc., based in New Jersey, has recalled 9,840 bottles of Morphine Sulfate extended-release ...